Intrinsic Value of S&P & Nasdaq Contact Us

R1 RCM Inc. RCM NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
53/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$17.11
+19.6%

R1 RCM Inc. (RCM) reported total assets of $4.96B and total liabilities of $2.21B for fiscal year 2023, resulting in total equity of $2.75B.

The company held $173.6M in cash and short-term investments. Total debt stood at $1.74B, with net debt of $1.57B. The Debt-to-Equity (D/E) ratio was 0.63 (moderate).

Current ratio is 1.83, indicating strong short-term liquidity. Interest coverage is 1.2x (weak).

Criteria supported by this page:

  • HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (49/100) — Total assets $4.96B and equity $2.75B support the company's competitive scale
  • VALUE (48/100) — Debt-to-Equity 0.63 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 53/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
53/100
SG Score
View full scorecard →
~
VALUE
48/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
58/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
49/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
30/100
→ Income
R1 RCM Inc. Balance Sheet History
Metric FY2023 FY2022 FY2021 FY2020
Total Assets $4.96B$5.14B$1.45B$1.19B
Total Liabilities $2.21B$2.42B$1.1B$849.6M
Total Debt $1.74B$1.9B$839.3M$635.2M
Cash & Investments $173.6M$110.1M$130.1M$173.8M
Total Stockholders Equity $2.75B$2.72B$346.7M$339.4M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message